(19)
(11) EP 4 370 094 A1

(12)

(43) Date of publication:
22.05.2024 Bulletin 2024/21

(21) Application number: 22746988.9

(22) Date of filing: 07.07.2022
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/36(2006.01)
A61K 9/70(2006.01)
A61K 31/485(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0056; A61K 9/7007; A61K 47/36; A61K 31/485
(86) International application number:
PCT/EP2022/068830
(87) International publication number:
WO 2023/285256 (19.01.2023 Gazette 2023/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.07.2021 EP 21185637

(71) Applicant: G.L. Pharma GmbH
8502 Lannach (AT)

(72) Inventors:
  • WACHTER, Christof
    8502 Lannach (AT)
  • KÜHBERGER, Elisabeth
    8502 Lannach (AT)
  • BEA, Manuel
    88499 Altheim (DE)
  • MITTER, Sabrina Janine
    88410 Bad Wurzach (DE)
  • HIESTAND, Bianca
    88444 Ummendorf (DE)
  • WAGNER, Wolfgang
    89233 Neu-Ulm (DE)
  • BECKERT, Thomas
    88447 Warthausen (DE)

(74) Representative: SONN Patentanwälte GmbH & Co KG 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) ORALLY DISINTEGRATING FILM COMPOSITION COMPRISING BUPRENORPHINE